Organisations can apply for a share of up to £450,000 for innovative technology to improve the diagnosis and management of skin conditions.
Award: Up to £150,000
Opens: 14th Nov 2016
Closes: 11th Jan 2016
The aim of this competition is to identify and fund innovative technology that improves diagnosis and ongoing management of skin conditions. The competition is particularly looking for solutions that:
NHS Scotland is looking for new solutions from industry partners that include, but are not limited to:
Innovations should result in these outcomes:
The proposed digital platforms used to provide these solutions should enable evidenced-based decision-making at every stage before onward referral.
Digital platforms should effectively and securely interface with existing NHS Scotland IT infrastructure. They should be user-friendly and work with the current technologies and devices used by citizens. Digital solutions should be flexible to allow for national and local development of the resource in line with service needs.
To lead a project, you must:
Funding and project details
NHS Scotland and Scottish Enterprise have allocated up to £450,000 to fund innovation projects in this competition.
This is divided across 2 phases:
In phase 1 you will show the technical feasibility of your proposed innovation. Projects can range in size up to a total cost of £30,000 each. Development contracts for feasibility studies should last up to 6 months. Phase 1 will have total funding of up to £150,000.
In the Phase 1 proposal, applicants should include their goals and an outline plan for Phase 2. This should cover testing in a live NHS system (see below). Proposals should also include an explicit plan for full commercial implementation.
Phase 2 is only open to applicants that have successfully completed phase 1. In phase 2, you will develop and evaluate prototypes or demonstrators of the more promising projects completed in phase 1. Projects should last up to 1 year. Projects can range in size up to a total cost of £150,000 each. Phase 2 will have total funding of up to £300,000.
The final 6 months of each contract in phase 2 will involve testing the shortlisted solutions in live healthcare settings at:
Successful proposals must demonstrate the ability to test at these facilities.